HIV Enrollment Formβœ…

HIV Enrollment Formβœ…

Questions

Concepts

Questions

Concepts

What do you want to do?

πŸ”˜ Enrol a new client

πŸ”˜ Transfer in a client

πŸ”˜ Enrol a Mother into PMTCT program

πŸ”˜ Re-enrol a client

166937 Care management plan

Enrolment Date

␣␣-␣␣-␣␣␣␣ πŸ“†

160555 Date enrolled in HIV care

Unique ID

__________________________________

162576 New patient identifier

Other Unique ID

__________________________________

162727 Other facility patient identifier

Entry Point

πŸ”½ Voluntary male circumcision clinic

πŸ”½ Private home-based care

πŸ”½ Adolescent outreach program

πŸ”½ Private Company

πŸ”½ Outreach program

πŸ”½ Community-based organization

πŸ”½ Outpatient department

πŸ”½ Pediatric inpatient service

πŸ”½ Voluntary counseling and testing program

πŸ”½ Maternal and child health program

πŸ”½ Vaccination service

πŸ”½ Nutrition program

πŸ”½ Sex worker outreach program

πŸ”½ Intravenous venous drug user outreach program

πŸ”½ Sexually transmitted infection program/clinic

πŸ”½ Under five clinic

πŸ”½ Tuberculosis treatment program

πŸ”½ Adult inpatient service

160540 Method of enrollment

Entry Point - Other

__________________________________

61011 Free text comment

Population Category

πŸ”˜ General population

πŸ”˜ Key population

πŸ”˜ Priority population

166432 Study population type

Key Population Type

πŸ”˜ Intravenous drug user

πŸ”˜ Male who has sex with men

πŸ”˜ Prisoners

πŸ”˜ Sex worker

πŸ”˜ Transgender Persons

166433 Target population type

Priority Population Type

πŸ”½ Adolescent Girls & Young Women

πŸ”½ Client of sex worker

πŸ”½ Fisher Folk

πŸ”½ Long-distance truck driver

πŸ”½ Migrant Workers

πŸ”½ Non-intravenous drug user

πŸ”½ Refugee

πŸ”½ Uniformed Forces

πŸ”½ Other

166433 Target population type

Β 

Transfer-In

Transferring Facility

__________________________________

160535 Transferred from location

Start ART Date

␣␣-␣␣-␣␣␣␣ πŸ“†

159599 Antiretroviral treatment start date

Regimen

πŸ”½ ABC + 3TC + DTG
πŸ”½ ABC + 3TC + EFV
πŸ”½ ABC + 3TC + LPV/r
πŸ”½ ABC + 3TC + NVP
πŸ”½ AZT + 3TC + ATV/r
πŸ”½ AZT + 3TC + DTG
πŸ”½ AZT + 3TC + EFV
πŸ”½ AZT + 3TC + LPV/r
πŸ”½ AZT + 3TC + NVP
πŸ”½ DRV/r + DTG + ABC + 3TC
πŸ”½ DRV/r + DTG + AZT + 3TC
πŸ”½ DRV/r + DTG + TDF + 3TC
πŸ”½ DRV/r + RAL + AZT + 3TC
πŸ”½ DRV/r + RAL + ABC + 3TC
πŸ”½ DRV/r + RAL + TDF + 3TC
πŸ”½ TDF + 3TC + ATV/r
πŸ”½ TDF + 3TC + DTG
πŸ”½ TDF + 3TC + EFV
πŸ”½ TDF + 3TC + LPV/r
πŸ”½ TDF + 3TC + NVP

164432 ARV regimen/code for drugs collected

Date of Enrolment into HIV Care

␣␣-␣␣-␣␣␣␣ πŸ“†

163260 Date of first visit

HIV Diagnosis

Date Confirmed HIV Positive

␣␣-␣␣-␣␣␣␣ πŸ“†

160554 Date of HIV diagnosis

Test Type

πŸ”˜ Rapid test for HIV

πŸ”˜ HIV DNA polymerase chain reaction

πŸ”˜ Unknown

164401 HIV test performed

Previous ARV/HAART Use

Β 

Indication/intent of therapy

β˜‘οΈ Pre Exposure Prophylaxis (PrEP)

β˜‘οΈ Prevention of Mother to Child Transmission (PMTCT)

β˜‘οΈ Post-exposure prophylaxis (PEP)

160846 Indication/intent of therapy

Use of Pre Exposure Prophylaxis (PrEP)
πŸ”˜ Yes
πŸ”˜ No
πŸ”˜ Unknown

166655 Pre-exposure prophylaxis (PrEP) regimen
1065 Yes

1066 No

1067 Unknown

Use of Post-exposure prophylaxis (PEP)***CC
πŸ”˜ Yes
πŸ”˜ No
πŸ”˜ Unknown

164845 Eligible for post-exposure prophylaxis
1065 Yes

1066 No

1067 Unknown

ART Use for Prevention of Mother to Child Transmission of HIV***CC
πŸ”˜ Yes
πŸ”˜ No
πŸ”˜ Unknown

163532 Mother enrolled in prevention of maternal to child transmission (PMTCT) program
1065 Yes

1066 No

1067 Unknown

Nucleoside Reverse Transcriptase Inhibitors (NRTIS)***CC
β˜‘οΈ Zidovudine
β˜‘οΈ Tenofovir
β˜‘οΈ Lamivudine
β˜‘οΈ Emtricitabine
β˜‘οΈ Abacavir
β˜‘οΈ Other antiretroviral drug

NRTIS Nucleoside Reverse Transcriptase Inhibitors (NRTIS) ARVs
86663 Zidovudine

84796 Tenofovir disoproxil

78643 Lamivudine

75628 Emtricitabine

70056 Abacavir

5424 Other antiretroviral drug

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)***CC
β˜‘οΈ Etravirine
β˜‘οΈ Nevirapine
β˜‘οΈ Efavirenz
β˜‘οΈ Other antiretroviral drug
β˜‘οΈ Unknown

NNRTIS Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS) ARVs
159810 Etravirine

80586 Nevirapine

75523 Efavirenz

5424 Other antiretroviral drug

1067 Unknown

Protease Inhibitors (PIS)***CC
β˜‘οΈ Tipranavir
β˜‘οΈ Saquinavir
β˜‘οΈ Ritonavir
β˜‘οΈ Fosamprenavir
β˜‘οΈ Darunavir
β˜‘οΈ Atazanavir

ProteaseInhibitorsProtease Inhibitors (PIS) ARVs
85160 Tipranavir

83690 Saquinavir

83412 Ritonavir

76658 Fosamprenavir

74258 Darunavir

71647 Atazanavir

Other HIV Drug Classes
β˜‘οΈ Raltegravir
β˜‘οΈ Dolutegravir
β˜‘οΈ Maraviroc
β˜‘οΈ Enfuvirtide
β˜‘οΈ Other antiretroviral drug
β˜‘οΈ Unknown

1193 Current drugs used
154378 Raltegravir

165085 Dolutegravir

154376 Maraviroc

75676 Enfuvirtide

5424 Other antiretroviral drug

1067 Unknown

Treatment Supporter

Β 

Treatment Supporter Name

__________________________________

160638 Name of treatment supporter

Treatment Supporter Phone Number

__________________________________

160642 Telephone number of treatment supporter

Treatment Supporter Relationship

πŸ”½ Sibling

πŸ”½ Parent

πŸ”½ Partner or spouse

πŸ”½ Guardian

πŸ”½ Grandparent

πŸ”½ Other

160640 Treatment supporter relationship to patient

Re-enrollment

Β 

Date of Re-enrollment

␣␣-␣␣-␣␣␣␣ πŸ“†

160753 Date of event

Reason For Re-enrolment

__________________________________

160632 Free text general